Featured 13F manager
Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site · 2021 Q3–2026 Q2
- $21.7B
- 77 Positions
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
Portfolio
top 5 29.9% · top 10 44.0%
- RVMD - Revolution Medicines 11.7%
- EA - Electronic Arts 7.5%
- BBIO - Bridgebio Pharma 3.7%
- PTGX - Protagonist Therapeutics 3.6%
- EXEL - Exelixis 3.4%
- LQDA - Liquidia 3.1%
- AMZN - Amazon 2.9%
- LNTH - Lantheus 2.9%
- NTRA - Natera 2.8%
- UNH - Unitedhealth Group 2.4%
- TMO - Thermo Fisher Scientific 2.4%
- ROIV - Roivant Sciences 2.3%
- Other 51.3%
AUM over time
Book
| UNH - Unitedhealth Group | 3.89% | Reduce −4.9% | 1,618,200 | $509.26 | $824M | −83,210 | −$18M |
| CRM - Salesforce | 3.58% | Add +51.0% | 2,946,838 | $257.10 | $758M | +994,670 | +$170M |
| IQV - IQVIA | 2.92% | Add +3.1% | 2,923,032 | $211.44 | $618M | +86,870 | −$99M |
| EXEL - Exelixis | 2.87% | Add +1.6% | 27,102,500 | $22.47 | $609M | +424,000 | −$24M |
| ARMK - Aramark | 2.72% | Reduce −5.0% | 16,929,237 | $34.02 | $576M | −893,700 | −$4M |
| AON - AON PLC · CL A | 2.60% | Add +196.7% | 1,875,200 | $293.58 | $551M | +1,243,200 | +$340M |
| MSFT - Microsoft | 2.54% | Reduce −0.7% | 1,202,778 | $446.95 | $538M | −8,680 | +$28M |
| NYT - New York Times · CL A | 2.40% | Reduce −11.3% | 9,919,840 | $51.21 | $508M | −1,268,219 | +$24M |
| NTRA - Natera | 2.28% | Add +13.6% | 4,460,557 | $108.29 | $483M | +532,874 | +$124M |
| NDAQ - Nasdaq | 2.13% | Reduce −11.0% | 7,506,719 | $60.26 | $452M | −930,000 | −$80M |
| TRU - Transunion | 2.11% | Reduce −5.0% | 6,035,119 | $74.16 | $448M | −316,137 | −$59M |
| INTU - Intuit | 1.95% | Add +17.1% | 629,097 | $657.21 | $413M | +92,019 | +$64M |
| TMO - Thermo Fisher Scientific | 1.93% | Reduce −7.3% | 739,156 | $553.00 | $409M | −58,260 | −$55M |
| RVMD - Revolution Medicines | 1.79% | Add +30.0% | 9,757,692 | $38.81 | $379M | +2,249,820 | +$137M |
| Sarepta Therapeutics | 1.71% | Reduce −6.5% | 2,295,000 | $158.00 | $363M | −158,500 | +$45M |
| NOW - Servicenow | 1.69% | Add +14.9% | 454,050 | $786.67 | $357M | +58,962 | +$56M |
| DIS - Disney Walt | 1.68% | New | 3,582,168 | $99.29 | $356M | +3,582,168 | +$356M |
| SPGI - S&P Global | 1.65% | Reduce −1.5% | 781,934 | $446.00 | $349M | −11,910 | +$11M |
| WAB - Wabtec | 1.63% | Reduce −25.9% | 2,189,498 | $158.05 | $346M | −766,900 | −$85M |
| CBRE - CBRE Group · CL A | 1.59% | Reduce −9.8% | 3,773,000 | $89.11 | $336M | −411,030 | −$71M |
| GOOG - Alphabet · CL C | 1.55% | Reduce −46.2% | 1,796,540 | $183.42 | $330M | −1,541,410 | −$179M |
| BSX - Boston Scientific | 1.49% | Reduce −10.6% | 4,109,157 | $77.01 | $316M | −487,500 | +$2M |
| ADI - Analog Devices | 1.38% | Reduce −16.5% | 1,284,800 | $228.26 | $293M | −253,190 | −$11M |
| ABNB - Airbnb · CL A | 1.22% | Add +5.8% | 1,701,000 | $151.63 | $258M | +92,780 | −$7M |
| AGIO - Agios Pharmaceuticals | 1.15% | Add +1.1% | 5,654,502 | $43.12 | $244M | +63,900 | +$80M |
| V - VISA · CL A | 1.02% | Add +20.7% | 821,886 | $262.47 | $216M | +141,036 | +$26M |
| YMM - Full Truck Alliance | 0.98% | Reduce −1.7% | 25,850,303 | $8.04 | $208M | −434,756 | +$17M |
| MA - Mastercard · CL A | 0.96% | Reduce −9.8% | 462,771 | $441.16 | $204M | −50,390 | −$43M |
| PTGX - Protagonist Therapeutics | 0.96% | Add +1.8% | 5,840,773 | $34.65 | $202M | +101,800 | +$36M |
| HWM - Howmet Aerospace | 0.93% | Reduce −25.5% | 2,541,839 | $77.63 | $197M | −868,920 | −$36M |
| SHW - Sherwin Williams | 0.91% | Reduce −14.1% | 647,550 | $298.43 | $193M | −106,280 | −$69M |
| AZNN — | 0.89% | Add +65.1% | 2,409,718 | $77.99 | $188M | +950,000 | +$89M |
| BEAM - Beam Therapeutics | 0.87% | Add +75.4% | 7,913,123 | $23.43 | $185M | +3,401,370 | +$36M |
| LNTH - Lantheus | 0.86% | Add +53.7% | 2,279,227 | $80.29 | $183M | +796,000 | +$91M |
| CNC - Centene Del | 0.68% | Reduce −16.9% | 2,168,175 | $66.30 | $144M | −439,700 | −$61M |
| Masimo | 0.67% | Reduce −24.8% | 1,119,563 | $125.94 | $141M | −370,000 | −$78M |
| EDU — | 0.54% | Add +139.0% | 1,469,590 | $77.73 | $114M | +854,590 | +$61M |
| THC - Tenet Healthcare | 0.43% | Add +7.8% | 687,442 | $133.03 | $91M | +50,000 | +$24M |
| Holding | 0.38% | Reduce −49.2% | 2,940,500 | $27.03 | $79M | −2,850,000 | −$46M |
| BHVN - Biohaven | 0.37% | Add +181.4% | 2,248,000 | $34.71 | $78M | +1,449,000 | +$34M |
| AMGN - Amgen | 0.34% | New | 232,000 | $312.45 | $72M | +232,000 | +$72M |
| GERN - Geron | 0.34% | Add +124.6% | 16,837,000 | $4.24 | $71M | +9,342,000 | +$47M |
| BEKE - KE | 0.32% | Hold | 4,740,833 | $14.15 | $67M | — | — |
| ICLR - ICON | 0.26% | Reduce −0.8% | 178,200 | $313.47 | $56M | −1,500 | −$5M |
| COR - Cencora | 0.26% | Reduce −27.3% | 242,800 | $225.30 | $55M | −91,200 | −$26M |
| Holding | 0.23% | New | 1,190,000 | $40.89 | $49M | +1,190,000 | +$49M |
| SIMO - Silicon Motion Technology | 0.22% | Reduce −33.7% | 567,534 | $80.99 | $46M | −287,915 | −$20M |
| UTHR - United Therapeutics | 0.21% | Add +30.0% | 143,000 | $318.55 | $46M | +33,000 | +$20M |
| INSM - Insmed | 0.18% | New | 568,000 | $67.00 | $38M | +568,000 | +$38M |
| PGNY - Progyny | 0.18% | Add +120.8% | 1,308,500 | $28.61 | $37M | +715,900 | +$15M |
| FLUT - Flutter Entmt | 0.17% | New | 200,800 | $182.36 | $37M | +200,800 | +$37M |
| CRSP - Crispr Therapeutics AG | 0.14% | New | 530,000 | $54.01 | $29M | +530,000 | +$29M |
| ENTA - Enanta Pharmaceuticals | 0.13% | Hold | 2,095,000 | $12.97 | $27M | — | — |
| LQDA - Liquidia | 0.12% | Hold | 2,055,000 | $12.00 | $25M | — | — |
| CRNX — | 0.11% | Add +9840.0% | 497,000 | $44.79 | $22M | +492,000 | +$22M |
| PCVX - Vaxcyte | 0.10% | Reduce −23.2% | 290,000 | $75.51 | $22M | −87,400 | −$4M |
| Savara | 0.09% | Add +90.5% | 4,560,000 | $4.03 | $18M | +2,165,701 | +$6M |
| VYGR - Voyager Therapeutics | 0.09% | Hold | 2,292,000 | $7.91 | $18M | — | — |
| CNTA - Centessa Pharmaceuticals | 0.09% | Add +438.0% | 1,996,000 | $9.03 | $18M | +1,625,000 | +$14M |
| SYRE - Spyre Therapeutics | 0.07% | Add +42.9% | 666,000 | $23.51 | $16M | +200,000 | −$2M |
| TAL - Tal Education Group | 0.07% | Hold | 1,365,000 | $10.67 | $15M | — | — |
| Zymeworks | 0.06% | Hold | 1,601,000 | $8.51 | $14M | — | — |
| PCG - Pg And E | 0.06% | Reduce −45.6% | 692,323 | $17.46 | $12M | −579,319 | −$9M |
| GDS — | 0.05% | Add +72.7% | 1,226,133 | $9.29 | $11M | +516,133 | +$7M |
| Elevation Oncology | 0.05% | Reduce −7.4% | 3,598,418 | $2.70 | $10M | −288,245 | −$10M |
| TWST - Twist Bioscience | 0.04% | New | 192,000 | $49.28 | $9M | +192,000 | +$9M |
| RIO - Rio Tinto | 0.04% | Hold | 137,500 | $65.93 | $9M | — | — |
| Ventyx Biosciences | 0.03% | Hold | 3,170,000 | $2.31 | $7M | — | — |
| ROIV - Roivant Sciences | 0.03% | Reduce −25.1% | 673,000 | $10.57 | $7M | −225,600 | −$2M |
| TECX - Tectonic Therapeutic | 0.03% | New | 431,010 | $16.47 | $7M | +431,010 | +$7M |
| Helix Acquisition Ii · CL A | 0.03% | Hold | 600,000 | $10.22 | $6M | — | — |
| Metals Acquisition | 0.03% | Add +160.4% | 410,197 | $13.69 | $6M | +252,697 | +$4M |
| CYTK - Cytokinetics | 0.03% | Hold | 102,400 | $54.18 | $6M | — | — |
| Metagenomi | 0.03% | Hold | 1,343,201 | $4.08 | $5M | — | — |
| NVAX - Novavax | 0.02% | Reduce −66.6% | 377,250 | $12.66 | $5M | −753,750 | −$630K |
| RARE — | 0.02% | Hold | 99,000 | $41.10 | $4M | — | — |
| PRME - Prime Medicine | 0.02% | Hold | 750,000 | $5.14 | $4M | — | — |
| COGT - Cogent Biosciences | 0.02% | Reduce −8.0% | 425,161 | $8.43 | $4M | −36,839 | +$479K |
| Swiftmerge Acquisition · CLASS A | 0.02% | Hold | 300,000 | $10.92 | $3M | — | — |
| Berenson Acquisition I · CL A | 0.01% | Hold | 285,715 | $10.65 | $3M | — | — |
| Biodesix | 0.01% | New | 1,878,175 | $1.53 | $3M | +1,878,175 | +$3M |
| Arya Sciences Acqu Iv · CL A | 0.01% | Hold | 200,000 | $11.46 | $2M | — | — |
| NRIX - Nurix Therapeutics | 0.01% | New | 108,799 | $20.87 | $2M | +108,799 | +$2M |
| AMLX - Amylyx Pharmaceuticals | 0.01% | Hold | 1,150,221 | $1.90 | $2M | — | — |
| Summit Midstream Partners | 0.01% | Hold | 58,214 | $35.56 | $2M | — | — |
| Marblegate Acquisition · CL A | 0.01% | Hold | 150,000 | $10.81 | $2M | — | — |
| VNET - VNET Group | 0.01% | Hold | 650,000 | $2.10 | $1M | — | — |
| QTRX - Quanterix | 0.00% | Reduce −83.0% | 80,000 | $13.21 | $1M | −391,000 | −$10M |
| Forte Biosciences | 0.00% | Hold | 1,810,455 | $0.5370 | $972K | — | — |
| MDGL - Madrigal Pharmaceuticals | 0.00% | Hold | 3,319 | $280.16 | $930K | — | — |
| Sage Therapeutics | 0.00% | Hold | 42,800 | $10.86 | $465K | — | — |
| Blueprint Medicines | 0.00% | Hold | 4,000 | $107.78 | $431K | — | — |
| Cara Therapeutics | 0.00% | Hold | 1,556,251 | $0.2580 | $402K | — | — |
| KRYS - Krystal Biotech | 0.00% | Hold | 2,000 | $183.64 | $367K | — | — |
| AXSM - Axsome Therapeutics | 0.00% | Hold | 4,000 | $80.50 | $322K | — | — |
| HCA - Hca Healthcare | 0.00% | Hold | 1,000 | $321.28 | $321K | — | — |
| GKOS - Glaukos | 0.00% | Hold | 2,600 | $118.35 | $308K | — | — |
| MMSI - Merit Med Sys | 0.00% | Hold | 3,000 | $85.95 | $258K | — | — |
| EHC - Encompass Health | 0.00% | Hold | 3,000 | $85.79 | $257K | — | — |
| BTSG - Brightspring Health Svcs | 0.00% | Hold | 22,000 | $11.36 | $250K | — | — |
| ARQT - Arcutis Biotherapeutics | 0.00% | Reduce −98.5% | 26,000 | $9.30 | $242K | −1,754,000 | −$17M |
| HQY - Healthequity | 0.00% | Hold | 2,800 | $86.20 | $241K | — | — |
| APLSUSD - Apellis Pharmaceuticals | 0.00% | Hold | 6,000 | $38.36 | $230K | — | — |
| IONS - Ionis Pharmaceuticals | 0.00% | Reduce −99.3% | 4,800 | $47.66 | $229K | −729,200 | −$32M |
| HUM - Humana | 0.00% | Reduce −98.8% | 600 | $373.65 | $224K | −51,100 | −$18M |
| ACLXGBX - Arcellx | 0.00% | Hold | 4,000 | $55.19 | $221K | — | — |
| CHE - Chemed | 0.00% | Hold | 400 | $542.58 | $217K | — | — |
| SBRA - Sabra Health Care Reit | 0.00% | Hold | 14,000 | $15.40 | $216K | — | — |
| IOVA - Iovance Biotherapeutics | 0.00% | Hold | 26,000 | $8.02 | $209K | — | — |
| SNDX - Syndax Pharmaceuticals | 0.00% | Hold | 10,000 | $20.53 | $205K | — | — |
| RNAGBP - Avidity Biosciences | 0.00% | Reduce −99.2% | 5,000 | $40.85 | $204K | −601,061 | −$15M |
| HIMS - Hims & Hers Health · CL A | 0.00% | Reduce −99.4% | 10,000 | $20.19 | $202K | −1,666,000 | −$26M |
| R1 Rcm | 0.00% | Hold | 16,000 | $12.56 | $201K | — | — |
| PACB — | 0.00% | Reduce −96.4% | 135,000 | $1.37 | $185K | −3,637,452 | −$14M |
| ALT - Altimmune | 0.00% | Reduce −94.1% | 27,600 | $6.65 | $184K | −442,400 | −$5M |
| GRFS - Grifols S A | 0.00% | Hold | 28,000 | $6.30 | $177K | — | — |
| OSCR - Oscar Health · CL A | 0.00% | Hold | 11,000 | $15.82 | $174K | — | — |
| ARDX - Ardelyx | 0.00% | Hold | 23,000 | $7.41 | $170K | — | — |
| AM6 - Amicus Therapeutics | 0.00% | Hold | 16,000 | $9.92 | $159K | — | — |
| CCCC - C4 Therapeutics | 0.00% | Hold | 28,000 | $4.62 | $129K | — | — |
| BYND - Beyond Meat | 0.00% | Hold | 19,000 | $6.71 | $127K | — | — |
| IRWD - Ironwood Pharmaceuticals · CL A | 0.00% | Hold | 13,000 | $6.52 | $85K | — | — |
| Lufax | 0.00% | Reduce −90.0% | 15,000 | $2.37 | $36K | −134,999 | −$597K |
Showing top 50 of 123 by value
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2024 Q1
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Pioneer Nat Res | 4.18% | Exit | 0 | $262.50 | $924M | −3,520,000 | −$924M |
| CSGP - Costar Group | 1.13% | Exit | 0 | $96.60 | $251M | −2,594,356 | −$251M |
| INSP - Inspire Med Sys | 0.61% | Exit | 0 | $214.79 | $135M | −626,854 | −$135M |
| VSTS - Vestis | 0.43% | Exit | 0 | $19.27 | $95M | −4,914,753 | −$95M |
| GBTC - Grayscale Bitcoin Tr Btc | 0.39% | Exit | 0 | $63.17 | $85M | −1,349,077 | −$85M |
| EVH - Evolent Health · CL A | 0.15% | Exit | 0 | $32.79 | $34M | −1,037,331 | −$34M |
| BABA - Alibaba Group | 0.11% | Exit | 0 | $72.36 | $24M | −329,000 | −$24M |
| APGE - Apogee Therapeutics | 0.09% | Exit | 0 | $66.45 | $20M | −305,000 | −$20M |
| ASND - Ascendis Pharma A/S | 0.07% | Exit | 0 | $151.17 | $16M | −109,000 | −$16M |
| Intra-Cellular Therapies | 0.07% | Exit | 0 | $69.20 | $16M | −231,000 | −$16M |
| Immunome | 0.07% | Exit | 0 | $24.68 | $15M | −594,000 | −$15M |
| Screaming Eagle Acquisitn · CLASS A | 0.05% | Exit | 0 | $10.70 | $11M | −1,000,000 | −$11M |
| Cazoo Group · CL A | 0.04% | Exit | 0 | $12.00 | $9M | −714,240 | −$9M |
| BRKR - Bruker | 0.04% | Exit | 0 | $93.94 | $8M | −83,100 | −$8M |
| Gossamer Bio | 0.03% | Exit | 0 | $1.18 | $7M | −6,130,272 | −$7M |
| PRAX — | 0.01% | Exit | 0 | $61.02 | $3M | −50,000 | −$3M |
| AVBP - Arrivent Biopharma | 0.01% | Exit | 0 | $17.86 | $3M | −151,768 | −$3M |
| SLNOEUR - Soleno Therapeutics | 0.01% | Exit | 0 | $42.81 | $1M | −27,750 | −$1M |
| ALNY - Alnylam Pharmaceuticals | — | Exit | 0 | $149.50 | $299K | −2,000 | −$299K |
| Springworks Therapeutics | — | Exit | 0 | $49.20 | $246K | −5,000 | −$246K |
| Alpine Immune Sciences | — | Exit | 0 | $39.66 | $234K | −5,900 | −$234K |
| ACHC — | — | Exit | 0 | $79.29 | $222K | −2,800 | −$222K |
| IDYA - Ideaya Biosciences | — | Exit | 0 | $43.80 | $219K | −5,000 | −$219K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
FARALLON CAPITAL MANAGEMENT, L.L.C.
87 processed 13Fs on this site · 2021 Q3–2026 Q2